Structure Therapeutics, Inc. (GPCR)
88.64
+3.62
(+4.26%)
USD |
NASDAQ |
Jan 16, 16:00
89.30
+0.66
(+0.74%)
Pre-Market: 20:00
Structure Therapeutics Market Cap: 5.105B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 929.39B |
| Novo Nordisk A/S | 276.96B |
| Pfizer Inc. | 145.84B |
| Viking Therapeutics, Inc. | 3.834B |
| Dyne Therapeutics, Inc. | 2.386B |
Market Cap Related Metrics
| PEG Ratio | -0.3739 |
| Price to Book Value | 6.630 |
| Price | 88.64 |
| Earnings Yield | -4.12% |
| PEGY Ratio | -0.3739 |